Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients

被引:68
作者
Nagashima, Takeshi [1 ,2 ]
Yamaguchi, Ken [3 ]
Urakami, Kenichi [1 ]
Shimoda, Yuji [1 ,2 ]
Ohnami, Sumiko [1 ]
Ohshima, Keiichi [4 ]
Tanabe, Tomoe [1 ,2 ]
Naruoka, Akane [5 ]
Kamada, Fukumi [1 ]
Serizawa, Masakuni [5 ]
Hatakeyama, Keiichi [4 ]
Matsumura, Kenya [1 ]
Ohnami, Shumpei [1 ]
Maruyama, Koji [6 ]
Mochizuki, Tohru [4 ]
Kusuhara, Masatoshi [5 ,7 ]
Shiomi, Akio [8 ]
Ohde, Yasuhisa [9 ]
Terashima, Masanori [10 ]
Uesaka, Katsuhiko [11 ]
Onitsuka, Tetsuro [12 ]
Nishimura, Seiichiro [13 ]
Hirashima, Yasuyuki [14 ]
Hayashi, Nakamasa [15 ]
Kiyohara, Yoshio [16 ]
Tsubosa, Yasuhiro [17 ]
Katagiri, Hirohisa [18 ]
Niwakawa, Masashi [19 ]
Takahashi, Kaoru [20 ]
Kashiwagi, Hiroya [21 ]
Nakagawa, Masahiro [22 ]
Ishida, Yuji [23 ]
Sugino, Takashi [24 ]
Takahashi, Mitsuru [25 ]
Akiyama, Yasuto [26 ]
机构
[1] Shizuoka Canc Ctr Res Inst, Canc Diagnost Res Div, Shizuoka, Japan
[2] SRL, Tokyo, Japan
[3] Shizuoka Canc Ctr, Shizuoka, Japan
[4] Shizuoka Canc Ctr Res Inst, Med Genet Div, Shizuoka, Japan
[5] Shizuoka Canc Ctr Res Inst, Drug Discovery & Dev Div, Shizuoka, Japan
[6] Shizuoka Canc Ctr Res Inst, Expt Anim Facil, Shizuoka, Japan
[7] Shizuoka Canc Ctr Res Inst, Reg Resources Div, Shizuoka, Japan
[8] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan
[9] Shizuoka Canc Ctr Hosp, Div Thorac Surg, Shizuoka, Japan
[10] Shizuoka Canc Ctr Hosp, Div Gastr Surg, Shizuoka, Japan
[11] Shizuoka Canc Ctr Hosp, Div Hepatobiliary Pancreat Surg, Shizuoka, Japan
[12] Shizuoka Canc Ctr Hosp, Div Head & Neck Surg, Shizuoka, Japan
[13] Shizuoka Canc Ctr Hosp, Div Breast Surg, Shizuoka, Japan
[14] Shizuoka Canc Ctr Hosp, Div Gynecol, Shizuoka, Japan
[15] Shizuoka Canc Ctr Hosp, Div Neurosurg, Shizuoka, Japan
[16] Shizuoka Canc Ctr Hosp, Div Dermatol, Shizuoka, Japan
[17] Shizuoka Canc Ctr Hosp, Div Esophageal Surg, Shizuoka, Japan
[18] Shizuoka Canc Ctr Hosp, Div Orthoped Oncol, Shizuoka, Japan
[19] Shizuoka Canc Ctr Hosp, Div Urol, Shizuoka, Japan
[20] Shizuoka Canc Ctr Hosp, Div Breast Oncol Ctr, Shizuoka, Japan
[21] Shizuoka Canc Ctr Hosp, Div Ophthalmol, Shizuoka, Japan
[22] Shizuoka Canc Ctr Hosp, Div Plast & Reconstruct Surg, Shizuoka, Japan
[23] Shizuoka Canc Ctr Hosp, Div Pediat, Shizuoka, Japan
[24] Shizuoka Canc Ctr Hosp, Div Pathol, Shizuoka, Japan
[25] Shizuoka Canc Ctr Hosp, Shizuoka, Japan
[26] Shizuoka Canc Ctr Res Inst, Immunotherapy Div, Shizuoka, Japan
基金
日本学术振兴会;
关键词
actionable alteration; cancer genome; driver alteration; individualized medicine; multi-omics analysis platform; SOMATIC MUTATIONS; DATABASE; VARIANTS; PATHWAYS; GENETICS; GENES; EXOME;
D O I
10.1111/cas.14290
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aimed to establish the Japanese Cancer Genome Atlas (JCGA) using data from fresh frozen tumor tissues obtained from 5143 Japanese cancer patients, including those with colorectal cancer (31.6%), lung cancer (16.5%), gastric cancer (10.8%) and other cancers (41.1%). The results are part of a single-center study called "High-tech Omics-based Patient Evaluation" or "Project HOPE" conducted at the Shizuoka Cancer Center, Japan. All DNA samples and most RNA samples were analyzed using whole-exome sequencing, cancer gene panel sequencing, fusion gene panel sequencing and microarray gene expression profiling, and the results were annotated using an analysis pipeline termed "Shizuoka Multi-omics Analysis Protocol" developed in-house. Somatic driver alterations were identified in 72.2% of samples in 362 genes (average, 2.3 driver events per sample). Actionable information on drugs that is applicable in the current clinical setting was associated with 11.3% of samples. When including those drugs that are used for investigative purposes, actionable information was assigned to 55.0% of samples. Germline analysis revealed pathogenic mutations in hereditary cancer genes in 9.2% of samples, among which 12.2% were confirmed as pathogenic mutations by confirmatory test. Pathogenic mutations associated with non-cancerous hereditary diseases were detected in 0.4% of samples. Tumor mutation burden (TMB) analysis revealed 5.4% of samples as having the hypermutator phenotype (TMB >= 20). Clonal hematopoiesis was observed in 8.4% of samples. Thus, the JCGA dataset and the analytical procedures constitute a fundamental resource for genomic medicine for Japanese cancer patients.
引用
收藏
页码:687 / 699
页数:13
相关论文
共 41 条
[1]   DoCM: a database of curated mutations in cancer [J].
Ainscough, Benjamin J. ;
Griffith, Malachi ;
Coffman, Adam C. ;
Wagner, Alex H. ;
Kunisaki, Jason ;
Choudhary, Mayank N. K. ;
McMichael, Joshua F. ;
Fulton, Robert S. ;
Wilson, Richard K. ;
Griffith, Obi L. ;
Mardis, Elaine R. .
NATURE METHODS, 2016, 13 (10) :806-807
[2]   Signatures of mutational processes in human cancer [J].
Alexandrov, Ludmil B. ;
Nik-Zainal, Serena ;
Wedge, David C. ;
Aparicio, Samuel A. J. R. ;
Behjati, Sam ;
Biankin, Andrew V. ;
Bignell, Graham R. ;
Bolli, Niccolo ;
Borg, Ake ;
Borresen-Dale, Anne-Lise ;
Boyault, Sandrine ;
Burkhardt, Birgit ;
Butler, Adam P. ;
Caldas, Carlos ;
Davies, Helen R. ;
Desmedt, Christine ;
Eils, Roland ;
Eyfjord, Jorunn Erla ;
Foekens, John A. ;
Greaves, Mel ;
Hosoda, Fumie ;
Hutter, Barbara ;
Ilicic, Tomislav ;
Imbeaud, Sandrine ;
Imielinsk, Marcin ;
Jaeger, Natalie ;
Jones, David T. W. ;
Jones, David ;
Knappskog, Stian ;
Kool, Marcel ;
Lakhani, Sunil R. ;
Lopez-Otin, Carlos ;
Martin, Sancha ;
Munshi, Nikhil C. ;
Nakamura, Hiromi ;
Northcott, Paul A. ;
Pajic, Marina ;
Papaemmanuil, Elli ;
Paradiso, Angelo ;
Pearson, John V. ;
Puente, Xose S. ;
Raine, Keiran ;
Ramakrishna, Manasa ;
Richardson, Andrea L. ;
Richter, Julia ;
Rosenstiel, Philip ;
Schlesner, Matthias ;
Schumacher, Ton N. ;
Span, Paul N. ;
Teague, Jon W. .
NATURE, 2013, 500 (7463) :415-+
[3]   A global reference for human genetic variation [J].
Altshuler, David M. ;
Durbin, Richard M. ;
Abecasis, Goncalo R. ;
Bentley, David R. ;
Chakravarti, Aravinda ;
Clark, Andrew G. ;
Donnelly, Peter ;
Eichler, Evan E. ;
Flicek, Paul ;
Gabriel, Stacey B. ;
Gibbs, Richard A. ;
Green, Eric D. ;
Hurles, Matthew E. ;
Knoppers, Bartha M. ;
Korbel, Jan O. ;
Lander, Eric S. ;
Lee, Charles ;
Lehrach, Hans ;
Mardis, Elaine R. ;
Marth, Gabor T. ;
McVean, Gil A. ;
Nickerson, Deborah A. ;
Wang, Jun ;
Wilson, Richard K. ;
Boerwinkle, Eric ;
Doddapaneni, Harsha ;
Han, Yi ;
Korchina, Viktoriya ;
Kovar, Christie ;
Lee, Sandra ;
Muzny, Donna ;
Reid, Jeffrey G. ;
Zhu, Yiming ;
Chang, Yuqi ;
Feng, Qiang ;
Fang, Xiaodong ;
Guo, Xiaosen ;
Jian, Min ;
Jiang, Hui ;
Jin, Xin ;
Lan, Tianming ;
Li, Guoqing ;
Li, Jingxiang ;
Li, Yingrui ;
Liu, Shengmao ;
Liu, Xiao ;
Lu, Yao ;
Ma, Xuedi ;
Tang, Meifang ;
Wang, Bo .
NATURE, 2015, 526 (7571) :68-+
[4]  
Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]
[5]   UniProt: a worldwide hub of protein knowledge [J].
Bateman, Alex ;
Martin, Maria-Jesus ;
Orchard, Sandra ;
Magrane, Michele ;
Alpi, Emanuele ;
Bely, Benoit ;
Bingley, Mark ;
Britto, Ramona ;
Bursteinas, Borisas ;
Busiello, Gianluca ;
Bye-A-Jee, Hema ;
Da Silva, Alan ;
De Giorgi, Maurizio ;
Dogan, Tunca ;
Castro, Leyla Garcia ;
Garmiri, Penelope ;
Georghiou, George ;
Gonzales, Daniel ;
Gonzales, Leonardo ;
Hatton-Ellis, Emma ;
Ignatchenko, Alexandr ;
Ishtiaq, Rizwan ;
Jokinen, Petteri ;
Joshi, Vishal ;
Jyothi, Dushyanth ;
Lopez, Rodrigo ;
Luo, Jie ;
Lussi, Yvonne ;
MacDougall, Alistair ;
Madeira, Fabio ;
Mahmoudy, Mahdi ;
Menchi, Manuela ;
Nightingale, Andrew ;
Onwubiko, Joseph ;
Palka, Barbara ;
Pichler, Klemens ;
Pundir, Sangya ;
Qi, Guoying ;
Raj, Shriya ;
Renaux, Alexandre ;
Lopez, Milagros Rodriguez ;
Saidi, Rabie ;
Sawford, Tony ;
Shypitsyna, Aleksandra ;
Speretta, Elena ;
Turner, Edward ;
Tyagi, Nidhi ;
Vasudev, Preethi ;
Volynkin, Vladimir ;
Wardell, Tony .
NUCLEIC ACIDS RESEARCH, 2019, 47 (D1) :D506-D515
[6]   TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data [J].
Bouaoun, Liacine ;
Sonkin, Dmitriy ;
Ardin, Maude ;
Hollstein, Monica ;
Byrnes, Graham ;
Zavadil, Jiri ;
Olivier, Magali .
HUMAN MUTATION, 2016, 37 (09) :865-876
[7]  
Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011
[8]   Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes [J].
Coombs, Catherine C. ;
Zehir, Ahmet ;
Devlin, Sean M. ;
Kishtagari, Ashwin ;
Syed, Aijazuddin ;
Jonsson, Philip ;
Hyman, David M. ;
Solit, David B. ;
Robson, Mark E. ;
Baselga, Jose ;
Arcila, Maria E. ;
Ladanyi, Marc ;
Tallman, Martin S. ;
Levine, Ross L. ;
Berger, Michael F. .
CELL STEM CELL, 2017, 21 (03) :374-+
[9]   Database of Genomic Biomarkers for Cancer Drugs and Clinical Targetability in Solid Tumors [J].
Dienstmann, Rodrigo ;
Jang, In Sock ;
Bot, Brian ;
Friend, Stephen ;
Guinney, Justin .
CANCER DISCOVERY, 2015, 5 (02) :118-123
[10]   Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics [J].
Ding, Li ;
Bailey, Matthew H. ;
Porta-Pardo, Eduard ;
Thorsson, Vesteinn ;
Colaprico, Antonio ;
Bertrand, Denis ;
Gibbs, David L. ;
Weerasinghe, Amila ;
Huang, Kuan-lin ;
Tokheim, Collin ;
Cortes-Ciriano, Isidro ;
Jayasinghe, Reyka ;
Chen, Feng ;
Yu, Lihua ;
Sun, Sam ;
Olsen, Catharina ;
Kim, Jaegil ;
Taylor, Alison M. ;
Cherniack, Andrew D. ;
Akbani, Rehan ;
Suphavilai, Chayaporn ;
Nagarajan, Niranjan ;
Stuart, Joshua M. ;
Mills, Gordon B. ;
Wyczalkowski, Matthew A. ;
Vincent, Benjamin G. ;
Hutter, Carolyn M. ;
Zenklusen, Jean Claude ;
Hoadley, Katherine A. ;
Wendl, Michael C. ;
Shmulevich, Llya ;
Lazar, Alexander J. ;
Wheeler, David A. ;
Getz, Gad .
CELL, 2018, 173 (02) :305-+